Abstract:Autism, Ahead of Print. Anecdotal reports link a distinct, bilateral, parieto-temporally generated 4.5-Hz rhythm on an electroencephalogram to a methylenetetrahydrofolate reductase gene variant co-occurring in autism spectrum disorder, but the validation of its precision is needed. The electroencephalograms of children with autism spectrum disorder showing the distinct bilateral parieto-temporally generated 4.5-Hz rhythm and their clinical chart report on polymerase chain reaction screening for methylenetetrahydrofolate reductase gene variants, 677C>T and 1298A>C, were retrieved from an outpatient clinic between February 2019 and April 2024. Twenty-five cases were identified. Patients were between 2 and 12 (7 ± 3) years old from Asian (n = 16, 64%), European (n = 5, 20%), African (n = 1, 4%) and mixed (n = 3, 12%) ethnicities. Twenty patients (80%) were positive for 677 C>Theterozygous (n = 3, 15%), 1298A>Cheterozygous (n = 8, 40%) or both (n = 9, 45%). The polymerase chain reaction testing detected neither variant in 5 (20%) patients. Therefore, the electroencephalogram-endophenotype showed 80% precision in identifying methylenetetrahydrofolate reductase gene variant within the sample. This preliminary data support the precision of the proposed distinct, bilateral, parieto-temporally generated 4.5-Hz rhythm in identifying methylenetetrahydrofolate reductase gene variants and its potential clinical applications as a valuable, non-invasive and objective measure within the population.Lay abstractMethylenetetrahydrofolate reductase mutations refer to genetic variations in the methylenetetrahydrofolate reductase enzyme, which plays an important role in folate metabolism. Folate is essential for neural development and signalling. Children with autism spectrum disorder have atypical neural signals compared with control. This study used a non-invasive method to identify a distinct neural signal that may be useful in future screening for methylenetetrahydrofolate reductase mutation in children with autism spectrum disorder. Given that the underlying causes of autism spectrum disorder have multiple genetic factors and often require subjective assessment, this study introduces a potential non-invasive screening method for methylenetetrahydrofolate reductase gene mutation. This method could provide valuable biomarkers for screening and personalised treatments, offering hope for improved risk stratification and bespoke nutritional support and supplements to mitigate the impact on affected individuals and their descendants.

Hypermethylation of the enolase gene ( ENO2 ) in autism

Complex epigenetic regulation of engrailed-2 (EN-2) homeobox gene in the autism cerebellum

Association of the ENGRAILED 2 (EN2) gene with autism in Chinese Han population.

Genome-wide DNA methylation profiles of autism spectrum disorder

Chromatin Remodeling Gene EZH2 Involved in the Genetic Etiology of Autism in Chinese Han Population.

Meta-analysis of Differentially Expressed Genes in Autism Based on Gene Expression Data.

Whole-transcriptome Analysis of Serum Neuron-Derived Exosomes Reveals Specific Signature for Autism Spectrum Disorder in Chinese Children

Biomarkers and pathways in autism spectrum disorder: An individual meta-analysis based on proteomic and metabolomic data

Prenatal Exposure of Diabetes and Progestin‐Mediated Autistic Biomarker in Peripheral Blood Mononuclear Cells

Locus-specific DNA methylation of Mecp2 promoter leads to autism-like phenotypes in mice

Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum

Epigenetic Insights into Autism Spectrum Disorder: DNA Methylation Levels of NR3C1, ASCL1, and FOXO3 in Korean Autism Spectrum Disorder Sibling Pairs

Short report on a distinct electroencephalogram endophenotype for MTHFR gene variation co-occurring in autism spectrum disorder

Sex differences in MAGEL2 gene promoter methylation in high functioning autism - trends from a pilot study using nanopore Cas9 targeted long read sequencing

Correlation Between Sialidase NEU1 Mrna Expression Changes in Autism Spectrum Disorder

Sex-specific DNA methylation signatures of autism spectrum disorder in newborn blood

Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies ( N = 1501)

Proteomics Study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children

Variation of Global DNA Methylation Levels with Age and in Autistic Children.

Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology

Differential Metabolites in Chinese Autistic Children: A Multi-Center Study Based on Urinary 1H-NMR Metabolomics Analysis